Canadian intraoperative MRI technology developer IMRIS has received the CE Mark for its MR imaging and x-ray angiography suite, the Winnipeg, Manitoba, company said.
With the approval, IMRIS will immediately begin marketing two products in Europe: IMRISNV for stroke management and advanced neurovascular interventions and IMRIScardio for cardiovascular interventions.
IMRISNV features a 3-tesla MRI scanner and a biplane angiography system specifically designed to coexist in the same suite; during and after the exam, new MR images can be acquired to assess the effectiveness of the treatment. IMRIScardio features a 1.5-tesla MRI scanner that helps physicians visualize the cardiovascular system before, during, and after an intervention, according to IMRIS.
Related Reading
IMRIS lands China install, April 16, 2009
IMRIS launches research initiative, February 20, 2009
IMRIS signs Yale, January 13, 2009
IMRIS takes first Australian order, January 7, 2009
IMRIS nets FDA OK for 3T MRI, December 19, 2008
Copyright © 2009 AuntMinnie.com
